Watch Ticker

Arcturus Therapeutics Holdings Inc. Common Stock

Go to Arcturus Therapeutics Holdings Inc. Common Stock Website

$12.20

-0.10 (-0.81%)

Live

Previous Close

$12.2

Day Range

$12.07 - $12.5499

Previous Day Range

$11.87 - $12.4056

Market Cap

$333.6 million USD

Day Vol.

296993

Previous Day Vol.

361590

Currency

USD

Primary Exchange

Nasdaq

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discove...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - RNA Therapeutics and RNA Vaccines Market Industry Report 2025-2035: Investments in RNA Technologies Surge with USD 2.9 Billion Funding

The global RNA therapeutics and vaccines market is projected to reach USD 940 million by 2035, growing at a CAGR of 68%, driven by advancements in RNA technologies and next-generation therapies.

Related tickers: ARCT, ATYR.

Read Full Article

Researchandmarkets.Com - Flu RNA Vaccines Market Research Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges

The global flu RNA vaccines market is expected to grow from $2.78 billion in 2025 to $5.95 billion by 2032, driven by advancements in mRNA technology and the need for rapid adaptation to evolving flu strains. North America leads the market, with notable growth in Europe and Asia-Pacific.

Related tickers: MRNA, PFE, BNTX, CVAC, SNY, GSK, ARCT.

Read Full Article

Trending Tickers

Please sign in to view